VolitionRx Limited is an international epigenetics firm that specializes in pioneering advanced blood tests. These diagnostics are developed to aid in the global detection of various cancers and other diseases. Their innovative product suite includes Nu.Q, engineered for cancer detection; Nu.Q Nets, which monitors immune system health; Nu.Q Vet, a cancer screening solution tailored for animal applications; Nu.Q Capture, designed to enhance diagnostic precision by concentrating samples; and Nu.Q Discover, a specialized platform for nucleosome profiling. The cornerstone of their blood test technology is their proprietary Nucleosomics platform. The company maintains its headquarters in Austin, Texas.